Stockbabie NewsFatherMarketNewsMarket Intelligence
MARKETS
Wire · Markets
Markets

Virax Biolabs Enter Agreements With Three Chinese Distributors For Its ImmuneSelect Research-Use Immune Profiling Products

Oct 29, 2026 · 07:44 AM ET· updated 59m ago

ImmuneSelect is Virax's commercially available research-use-only ("RUO") immune profiling portfolio and is distinct from ViraxImmune™, the Company's in-development diagnostic platform. The appointments

Share
Why It Matters

Virax signed deals with three Chinese companies to sell research products. This shows the company is expanding where its tools are used.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
VRAX1.31
+0.11 (+9.17%)

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.